Učitavanje...
Clinical safety and efficacy of World’s thinnest (50 μm), very long (>40 mm) Everolimus Eluting Stent (SES) among real world patients
Background: Safety and efficacy of newer-generation and World’s thinnest everolimus eluting stent (Evermine 50) in patients with very long and multiple lesions. Method: Total of 711 patients received >40 mm long, World’s thinnest (50 µm) Evermine 50 Everolimus eluting stent (Meril Life Sciences P...
Spremljeno u:
| Izdano u: | Am J Cardiovasc Dis |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
e-Century Publishing Corporation
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675176/ https://ncbi.nlm.nih.gov/pubmed/33224579 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|